People | December 14, 2023
Moderna Chief Commercial Officer steps down, President to look over pipeline strategy
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
General Medicine grows 5% and Vaccines 10% led by Shingrix
PhytoSquene now available for clinical and commercial use
Lack of technology transfer stands out as a formidable barrier
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Subscribe To Our Newsletter & Stay Updated
